Flusoxolol
- Level
- Commodity
- Parent
- 51262900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51262902This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1GPL60IRCI. European Medicines Agency schedules Flusoxolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07753MIG. Flusoxolol generally arises in the molecular formula C22H30FNO4. The term FLUSOXOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) FLUSOXOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flusoxolol under HS 29221980 and SITC 51461. As of Q4 2014, FLUSOXOLOL remains the US FDA Preferred Term for this commodity. Flusoxolol bears US NLM identifiers UMLS ID C0117994 and NCI Concept Code C73018. SMILES: FC1CCC(CCOCCOC2CCC(OCC(O)CNC(C)C)CC2)CC1.
Same parent
Under 51262900 · 14Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.